Stay updated on Comparing Fenebrutinib vs Teriflunomide in RMS Clinical Trial
Sign up to get notified when there's something new on the Comparing Fenebrutinib vs Teriflunomide in RMS Clinical Trial page.

Latest updates to the Comparing Fenebrutinib vs Teriflunomide in RMS Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe 403 error block and its HTML boilerplate (including the 403 text and Home link) were removed from the page.SummaryDifference0.5%

- Check15 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study details with an access-denied message. This prevents viewing the study record and related information on the page.SummaryDifference18%

- Check29 days agoChange DetectedThe study page adds a new site in New Delhi (Sir Gangaram Hospital) and updates overall locations, while introducing new/modified outcomes such as T1Gd+ lesion counts, an SDMT worsening definition, and NfL biomarker measurements with extended timeframes; the Pune site (Sahyadri Hospital) has been removed.SummaryDifference0.9%

- Check36 days agoChange DetectedRevision: v3.6.6 replaces the previous Revision: v3.6.5 on the page. This reflects a newer build of the site’s software used for the study detail page.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing Revision: v3.6.4. This indicates a software version update for the site.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page revision label updated from v3.6.3 to v3.6.4. This indicates a minor update to the study record on the ClinicalTrials.gov page.SummaryDifference0.0%

Stay in the know with updates to Comparing Fenebrutinib vs Teriflunomide in RMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Fenebrutinib vs Teriflunomide in RMS Clinical Trial page.